Cargando…
Hairy cell leukemia: short review, today's recommendations and outlook
Hairy cell leukemia (HCL) is part of the low-grade non-Hodgkin lymphoma family and represents approximately 2% of all leukemias. Treatment with splenectomy and interferon-α historically belonged to the first steps of therapeutic options, achieving partial responses/remissions (PR) in most cases with...
Autores principales: | Maevis, V, Mey, U, Schmidt-Wolf, G, Schmidt-Wolf, I G H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944661/ https://www.ncbi.nlm.nih.gov/pubmed/24531447 http://dx.doi.org/10.1038/bcj.2014.3 |
Ejemplares similares
-
The Biology of Classic Hairy Cell Leukemia
por: Bohn, Jan-Paul, et al.
Publicado: (2021) -
Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019) -
Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017) -
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant
por: Locher, Maurus, et al.
Publicado: (2020) -
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022)